Fixed-duration ibrutinib–venetoclax versus chlorambucil–obinutuzumab in previously untreated chronic lymphocytic leukaemia (GLOW): 4-year follow-up from a multicentre, open-label, randomised, phase 3 trial - The Lancet Oncology
Pierre Paulin's desk, model CM 141, Thonet edition 1954 - OAK
goedkope game bureau's met carbonprint kopen | aktiewonen.nl